Scientific Programme

Where speakers have provided approval to share the slides/posters from their presentations, these are available by clicking on the title of the presentation below.

Thursday 4 April

Keynote Lecture: The Safety of Antiretroviral Drugs During the First Trimester of Pregnancy
Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA

Keynote Lecture: Treatment and Prevention in Adolescents and their Transition to Adult Care
Allison Agwu, Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Keynote Lecture: HPV in HIV: state-of-the-art for clinicians
Tim Wilkin, Weill Cornell Medicine, New York, NY, USA

HPV in HIV: Current anal cancer screening practices in HIV positive MSM population: a single centre, 10-year follow-up study in Mexico City
Rodrigo Ville-Benavides, Infectious Diseases Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Keynote Lecture: First-line Therapy in the Region
Pedro Cahn, Fundación Huésped, Buenos Aires, Argentina

Keynote Lecture: Simplifying and personalising HCV care
Mark S Sulkowski, Divisions of Infectious Diseases and Gastroenterology/Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Back to the top of the page

Friday 5 April

Keynote Lecture: Challenges of TB/HIV in the region
Alicia Piñeirúa‐Menendez, Clínica Especializada Condesa Iztapalapa, Mexico City, Mexico

Substantial declines in HIV, syphilis, genital ulcers, and urethral discharge over 2 decades, with recent increases in STI prevalence in a sexually transmitted infection clinic in urban Haiti
Poster-O212
Bernard Liautaud, Medicine, GHESKIO, Port-au-Prince, Haiti

Factors associated with disengagement from HIV care at GHESKIO, main HIV centre in the Caribbean
Poster-O213
Marie M Deschamps, Global Health, GHESKIO, Port-au-Prince, Haiti

Keynote Lecture: The Future of ART and Cure Update
Daniel R Kuritzkes, Harvard Medical School and Brigham Women’s Hospital, Boston, MA, USA

HIV and Ageing – A role for inflammation?
Peter Hunt, University of California San Francisco, San Francisco, CA, USA

HIV and Ageing – Ageing gracefully with HIV: Challenges and Goals
Julian Falutz, Division of Geriatrics, Montreal General Hospital, Montreal, Canada

HIV and Ageing – Fragility fractures and risk assessment in a cohort of adult women living with HIV in Argentina
Marcelo Laurido, Infectious Diseases, Helios Salud, Buenos Aires, Argentina

Key Topics in Hepatitis
Non-viral liver disease and HIV/NASH
Mário G Pessoa, University of of São Paulo, São Paulo, Brazil

Hepatitis C eradication: is it for real in this day and age of economic constriction?
Jorge L Santana, University of Puerto Rico School of Medicine, San Juan, Puerto Rico

The impact of HEV infection on the disease severity of patients with chronic HCV infection
Mário G Pessoa

Hepatitis B: is cure on the agenda?
Mark Nelson, Chelsea and Westminster Hospital, London, UK

CROI 2019 Review
Luis Soto Ramirez, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Back to the top of the page

Saturday 6 April

Public Health HIV Programs of Latin America and the Caribbean Moving Beyond NNRTI-based First-line Regimens
Session in collaboration with the Pan American Health Organization (PAHO)
Landscape of current HIV care and treatment policies and practices
Giovanni Ravasi, PAHO, Washington, DC, USA

The emerging threat of HIV drug resistance: findings to accelerate transition
Santiago Avila-Rios, Center for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico

Experience with dolutegravir in first-line treatment in Brazil: the first 100,000 patients
Ana Roberta Patti Pascom, Department of STI, HIV/AIDS and Viral Hepatitis, Ministry of Health, Brasilia, Brazil

ART and sexual and reproductive health of women living with HIV: challenges and opportunities
Rebecca Zash, Reproductive Health, Harvard University Center for AIDS Research, Cambridge, MA, USA

The role of civil society in the evolving HIV treatment programs: Lessons learned and recommendations
Javier Hourcade Bellocq, Buenos Aires, Argentina

Barriers and Facilitators to Early Treatment and PrEP Implementation in the Region
In collaboration with the International AIDS Society
PrEP 2019: Where are we now?
Kenneth Mayer

The Brazilian Implementation Plan
Adele Schwartz Benzaken, São Paulo, Brazil

Sexual health clinics and PrEP implementation in Buenos Aires
Marcelo Losso, HIV Unit, Hospital Ramos Mejia, Buenos Aires, Argentina

PrEP implementation in transgender women
Florentino Badial Hernández, Clínica Especializada Condesa Iztapalapa, Mexico City,
Mexico